The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105 395 13,263 SH   SOLE   13,263 0 0
ADIENT PLC ORD SHS G0084W101 344 4,737 SH   SOLE   4,737 0 0
AGILE THERAPEUTICS INC COM 00847L100 5,204 1,623,567 SH   SOLE   1,623,567 0 0
BERKSHIRE HATHAWAY INC DEL CL B NEW 084670702 1,491 8,945 SH   SOLE   8,945 0 0
CIDARA THERAPEUTICS INC COM 171757107 162 20,802 SH   SOLE   20,802 0 0
CM FIN INC COM 12574Q103 540 53,204 SH   SOLE   53,204 0 0
GARRISON CAP INC COM 366554103 646 66,073 SH   SOLE   66,073 0 0
JAZZ PHARMACEUTICALS PLC SHS USD G50871105 289 1,992 SH   SOLE   1,992 0 0
STRONGBRIDGE BIOPHARMA PLC SHS USD G85347105 25,626 5,394,994 SH   SOLE   5,394,994 0 0
TEAM HEALTH HOLDINGS INC COM 87817A107 336 7,713 SH   SOLE   7,713 0 0